NCCN Guidelines for Patients® | Ovarian Cancer - page 43

Part 5: Treatment with cancer drugs
NCCN Guidelines for Patients
: Ovarian cancer
Version 1.2013
Par t 1
Par t 2
Par t 3
Par t 4
Par t 5
Par t 6
Par t 7
Par t 8
Par t 9
Par t 10
The belly area
between the chest and
A pair of organs
that filter blood and remove
waste from the body
through urine
Neoadjuvant treatment:
Treatment given before
surgery to remove a tumor
A treatment plan
that specifies the dosage,
schedule, and duration of
Regional treatment:
Treatment with cancer-
killing drugs directed to a
specific area of the body
Chemotherapy is given in cycles of treatment days followed by days of rest.
These cycles vary in length depending on which drugs are used. Often, the
cycles are 14, 21, or 28 days long. These cycles give the body a chance to
recover before the next treatment. The number of treatment days per cycle and
the total number of cycles varies depending on the chemotherapy drug given.
Which chemotherapy drug you receive depends on several factors such as your
overall health (performance status), how well your kidneys work, and risk for
neuropathy. Performance status is a rating of your ability to do daily activities. It
is important that your kidneys are working well if you may receive a combination
of IV and IP chemotherapy.
Your doctor may give a blood test to assess for chemicals normally filtered out
of the blood by your kidneys. High levels of certain chemicals may be a sign
that your kidneys aren’t working well (poor kidney function). Neuropathy is a
nerve problem that causes pain, tingling, and numbness in the hands and feet.
If you have a poor performance status, poor kidney function, or a high risk for
neuropathy, then IP chemotherapy may not be a good treatment option for you.
Part 5 Contents
Chemotherapy treatment recommendations:
page 46
Monitoring tests during chemotherapy treatment:
page 48
Post-chemotherapy treatment:
page 49
1...,33,34,35,36,37,38,39,40,41,42 44,45,46,47,48,49,50,51,52,53,...100
Powered by FlippingBook